Want to join the conversation?
$AN 2Q15 Q&A: Whiston of Morningstar asked about the plans for commercial paper proceeds. Cheryl told that it’s lower cost to capital. It’s general corporate uses, it could be anything from rebuild acquisitions and CapEx. So it’s opportunistic pricing standpoint relative to the rates that AN is paying under broad revolving credit facility.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?